A dose determination study of NS-580 in patients with endometriosis (late phase II)
Phase 2
- Conditions
- endometriosis
- Registration Number
- JPRN-jRCT2031210685
- Lead Sponsor
- Higashioka Masaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- 372
Inclusion Criteria
Patients who are clinically diagnosed with endometriosis
-Patients whose severity of pelvic pain caused by endometriosis meets selection criteria
-Patients with regular menstrual cycle
-Patients aged 20 years or older and 49 years or younger (at the time of informed consent)
Exclusion Criteria
-Patients for whom surgical treatment of organic diseases is considered to be prioritized by the investigator or subinvestigator
-Patients aged 40 years or older (at the time of consent) with a longest diameter of ovarian chocolate cyst exceeding 10cm
-Patients with solid image in ovarian chocolate cyst
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pelvic pain
- Secondary Outcome Measures
Name Time Method